Nexgel (NXGL) Operating Expenses (2018 - 2025)

Nexgel has reported Operating Expenses for 8 years, with the latest figure at $2.0 million in Q4 2025.

• For the quarter ending Q4 2025, Operating Expenses rose 6.16% year-over-year to $2.0 million; the trailing twelve-month figure through Dec 2025 stood at $7.9 million (up 26.04% YoY), and the FY2025 full-year result was $7.9 million, up 24.74% from the prior year.
• Operating Expenses for Q4 2025 stood at $2.0 million, up from $2.0 million in the prior quarter.
• The five-year high for Operating Expenses was $2.0 million in Q4 2025, with the low at $478000.0 in Q1 2021.
• Historically, Operating Expenses has averaged $1.2 million across 5 years, with a median of $1.0 million in 2021.
• Annual changes were most pronounced in 2022 — Operating Expenses surged 114.29% — and 2023, when it decreased 19.32%.
• Nexgel's Operating Expenses stood at $990000.0 in 2021, then slipped by 17.47% to $817000.0 in 2022, then surged by 38.56% to $1.1 million in 2023, then soared by 69.17% to $1.9 million in 2024, then gained by 6.16% to $2.0 million in 2025.
• The last three Operating Expenses figures came in at $2.0 million (Q4 2025), $2.0 million (Q3 2025), and $1.9 million (Q2 2025), per Business Quant data.